Basics Relmada Therapeutics, Inc. IPO Date: June 16, 2014 Sector: Healthcare Industry: Biotech Market Cap: $75.01M Activated in VL: True Average Daily Range Avg Daily Range: $0.53 | 3.85% Avg Daily Range (30 D): $0.12 | 5.93% Avg Daily Range (90 D): $0.07 | 6.13% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .33M Avg Daily Volume (90 D): .48M Trade Size Avg Trade Size (Sh.): 135 Avg Trade Size (Sh.) (30 D): 191 Avg Trade Size (Sh.) (90 D): 299 Institutional Trades Total Inst.Trades: 366 Avg Inst. Trade: $2.18M Avg Inst. Trade (30 D): $.6M Avg Inst. Trade (90 D): $.6M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.27M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 102.03K     News Jul 31, 2025 @ 11:00 AM Relmada Therapeutics to Report Second Quarter 2025... Source: Corporate Communications Apr 28, 2025 @ 5:38 PM Relmada Therapeutics Presents Positive Initial Pha... Source: N/A Apr 27, 2025 @ 1:00 PM UPDATE -- Relmada Therapeutics To Present NDV-01 D... Source: N/A Feb 25, 2025 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Dec 9, 2024 @ 12:30 PM Relmada Therapeutics to Discontinue the Reliance I... Source: Globe Newswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.3 $-.58 $-.62 Diluted EPS $-.3 $-.58 $-.62 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -9.87M $ -17.56M $ -18.66M Operating Income / Loss $ -10.22M $ -18.22M $ -19.08M Cost of Revenue $ $ $ Net Cash Flow $ -2.5M $ M $ 2.37M PE Ratio     Splits Sep 30, 2019:   1:4 Aug 12, 2015:   1:5